Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Dyadic International Inc DYAI

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and... see more

Current News (NDAQ:DYAI)

Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets

GlobeNewswire December 17, 2025

Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic's Recombinant Growth Factors and Media Proteins

GlobeNewswire December 15, 2025

Updated Lineup Announced for iAccess Alpha's Virtual Best Ideas Winter Investment Conference December 9-10, 2025

ACCESS Newswire December 8, 2025

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets

GlobeNewswire December 1, 2025

Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress

GlobeNewswire November 12, 2025

Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics

GlobeNewswire November 10, 2025

Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025

GlobeNewswire October 29, 2025

Dyadic Applied BioSolutions Announces Milestone Achievements and Recent Company Developments

GlobeNewswire October 6, 2025

Dyadic to Present at Investor Conferences and BPI East

GlobeNewswire September 4, 2025

Opinion & Analysis (NDAQ:DYAI)

No current opinion is available.

Bullboard Posts (NDAQ:DYAI)

Buy buddy buy.

FOMO for you fellas out there today anyway
coolfooldumbguy - December 1, 2025

DYAI: Moo-ve Over Bovines, C1’s Taking On Albumin

http://beyondspx.com/2024/08/01/dyai-moo-ve-over-bovines-c1s-taking-on-albumin/
MikeTester - August 1, 2024

Dyadic International, Inc. and Proliant Health ...

JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have...
AveragePenny - June 28, 2024

Dyadic to Attend Industry Events in June

JUPITER, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a biotechnology...
AveragePenny - May 31, 2024

Dyadic Announces First Quarter 2024 Financial Results

News Link: https://www.globenewswire.com/news-release/2024/05/14/2881828/0/en/Dyadic-Announces-First-Quarter-2024-Financial...
AveragePenny - May 15, 2024

Dyadic to Attend Industry and Investor Events in May

JUPITER, Fla., May 08, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global...
AveragePenny - May 8, 2024